Dr’s Paul Skipp and Jim Schofield have had their paper accepted for publication in the American Journal of Respiratory and Critical Care Medicine.
http://www.atsjournals.org/doi/abs/10.1164/rccm.201604-0866OC
The paper “A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts” represents the first of many papers from the Centre for Proteomic Research who were involved in the proteomics, lipidomics and bioinformatic analysis from this large-scale collaborative project.
U-BIOPRED, which stands for Unbiased BIomarkers for the Prediction of REspiratory Disease outcomes, is a 23M Euro project funded by the Innovative Medicines Initiative (IMI) between 2010-2016. By bringing together scientists from universities, research institutes, the pharmaceutical industry and small companies with asthma patients and patient organisations, this project aimed to understand more about severe asthma and to uncover new information and ideas leading to the creation of effective new treatments.
If you would like to know more about the U-BIOPRED project and keep up-to-date with forthcoming publications please visit http://www.europeanlung.org/en/projects-and-research/projects/u-biopred/home